We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session

Head and neck
6000
Poster (digital)
Clinical
NLR and PLR ratio as predictive markers of outcomes in head and neck squamous cell carcinoma
Lucrezia Gasparini, Italy
PO-1073
Prognostic factors analysis of carcinoma ex pleomorphic adenoma of major salivary glands
Yu Hsuan Chang, Taiwan
PO-1074
Results of Concurrent SBRT and Immunotherapy in Recurrent and Metastatic Head and Neck Cancer
Melek Tugce Yilmaz, Turkey
PO-1075
Do patients with rmHNC treated with checkpoint inhibitors benefit form additional radiotherapy?
Bálint Tamaskovics, Germany
PO-1076
Evaluation of Vascular and Nerve Changes in Nasopharyngeal Carcinoma Patients Following Radiotherapy
Meltem Dağdelen, Turkey
PO-1077
Obesity potential biomarker for prediction of OS in head and treated with radio-chemotherapy
Giovanni Gadducci, Italy
PO-1078
An optimal assessment schedule in the head and neck cancer using parametric modeling
Hye In Lee, Korea Republic of
PO-1079
Dosimetric Evaluation of Risk of Osteoradionecrosis (DERO): setting-up and first results.
Marion Renouf, France
PO-1080
BMI and SMI variations in HNSCC patients undergoing radiotherapy and nutritional intervention
Federico Mastroleo, Italy
PO-1081
CECT vs. MRI: Impact of concordance index for gross target volume in IMRT of head and neck cancers
Pallavi Kalbande, India
PO-1082
Sleep disturbances in head and neck cancer survivors one year after radiation therapy.
Vanessa Jerviz Guia, Spain
PO-1083
Relapse pattern in relation to FDG-PET and target volumes in HPV positive/negative oropharynx cancer
Katrin Håkansson, Denmark
PO-1084
Impact of multidisciplinary target review in head and neck radiation
Kaoutar SOUSSY, Morocco
PO-1085
Head and neck cancer of unknown primary: recurrence pattern based on treatment volumes
Annamaria Guaineri , Italy
PO-1086
Tumour volume response to induction chemotherapy in nasopharyngeal carcinoma: TPF versus GP
Omar Nouri, Tunisia
PO-1087
TOXICITY PROFILE OF 100 OROPHARYNGEAL CANCER PATIENTS TREATED WITH MODERN APPROACHES
Daniela Alterio, Italy
PO-1088
Antibiotic use goes along with reduced survival in head-and-neck cancer patients after radiotherapy
Alexander Rühle, Germany
PO-1089
Late toxicity-related symptoms and fraction dose affect decision regret in HNC patients
Muemtaz Koeksal, Germany
PO-1090
GTV as prognostic marker in head and neck cancer - Time to redefine GTV beyond contouring
Imtiaz Ahmed, India
PO-1091
Clinical implication of different treatment techniques in glottic cancer
Laura Cardoso Rubio, Spain
PO-1092
Effect of primary tumor volume on the clinical outcomes of nasopharyngeal carcinoma
Asim Hafiz, Pakistan
PO-1093
Long term outcomes of 630 consecutive patients of oropharyngeal cancer treated with radiotherapy
Ashwini Budrukkar, India
PO-1094
pre-treatment salivary flow predicts recovery of salivary flow after IMRT for head and neck cancer
Shinya Hiraoka, Japan
PO-1095
Long-term results of postoperative radiochemotherapy with weekly cisplatin in head and neck cancer
VICTOR DUQUE-SANTANA, Spain
PO-1096
Helium-Neon laser to treat radiation induced oral mucositis in oral cancer- A comparative study
Tasneem Nalawala, India
PO-1097
Head and neck cancer mastication structure doses by older and newer external beam RT techniques
Niclas Pettersson, Sweden
PO-1098
Split course hypofractionated radiotherapy in elderly and frail patients with head and neck cancers.
Karol Paciorek, Poland
PO-1099
Impact of sarcopenia in oropharyngeal cancer patients treated with radical chemo-radiotherapy
chiara lucrezia deantoni, Italy
PO-1100
Early NGT insertion prevents weight loss & treatment breaks in post-op CTRT and QoL assessment.
ajay gv, India
PO-1101
Effect of bio adhesive barrier forming oral liquid on radiation induced Oral mucositis HNSCC
Ashalatha Devalla, India
PO-1102
Results of postoperative radiotherapy in salivary gland tumors: a 10-years’ experience
Olga Engel, Spain
PO-1103
Impact of pre-treatment inflammatory markers in head and neck cancer treated with chemoradiotherapy
Deep Shankar Pruthi, India
PO-1104
Prognostic analysis of different T classification in N3 nasopharyngeal carcinoma patients
Shao-Wei Chiang, Taiwan
PO-1105
HPV Status and Fitness Associated With Aspiration Risk at One Year After Head and Neck Radiotherapy
Eliana Maria Vasquez Osorio, United Kingdom
PO-1106
miR-9 as predictor of response to Radiotherapy and Cetuximab in patients with head and neck cancers
Giuseppe Fanetti, Italy
PO-1107
Predicting radiation-induced neurocognitive decline in patients with brain or head & neck tumor
Fariba Tohidinezhad, The Netherlands
PO-1108
Treatment outcomes for HPV-associated tonsillar cancer: a single-institution experience of 374 cases
Joongyo Lee, Korea Republic of
PO-1109
Survival outcomes in Hypopharyngeal Squamous Cell Cancers in the West of Scotland Cancer Network
Wai-Yan Poon, United Kingdom
PO-1110
Hypoxia and Perfusion MR-Imaging on the MR-Linear Accelerator for Head and Neck Cancer
Amit Gupta, United Kingdom
PO-1111
Relationship between weight loss during IMRT and outcomes in patients with head and neck cancer
Kenji Makita, Japan
PO-1112
Predictive Factors for Response to Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer
Jens von der Grün, Switzerland
PO-1113
Intensity Modulated Radiotherapy (IMRT) after conservative surgery for supraglottic tumours
Daniela Alterio, Italy
PO-1114
First year survival data on COVID-19 outbreak during radiotherapy course in head and neck cancer
Anna Bandurska-Luque, Poland
PO-1115
Towards Privacy-Preserving Federated Deep Learning infrastructure : proof-of-concept
Chong Zhang, The Netherlands
PO-1116
Clinical and pathological prognostic factors in postoperative locally advanced head and neck cancer
Jose Antonio Domínguez Rullán, Spain
PO-1117
PTV changes analysis throughout treatment in H&N patients
Laura Cardoso Rubio, Spain
PO-1118
Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
Tae Hoon Lee, Korea Republic of
PO-1119
The potential value of MRI in response evaluation after primary (C-)RT for head and neck cancer
Sandy Mohamed, Egypt
PO-1120
Acoustic analysis of voluntary and reflexive coughs in healthy subjects
Sofiana Mootassim-Billah, Belgium
PO-1121
Prospective assessment of diurnal variation of Xerostomia in treated head neck cancer (HNC) patients
Sharmila Agarwal, India
PO-1122